1. Home
  2. LGND vs NHI Comparison

LGND vs NHI Comparison

Compare LGND & NHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • NHI
  • Stock Information
  • Founded
  • LGND 1987
  • NHI 1991
  • Country
  • LGND United States
  • NHI United States
  • Employees
  • LGND 68
  • NHI N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • NHI Real Estate Investment Trusts
  • Sector
  • LGND Health Care
  • NHI Real Estate
  • Exchange
  • LGND Nasdaq
  • NHI Nasdaq
  • Market Cap
  • LGND 3.2B
  • NHI 3.7B
  • IPO Year
  • LGND 1992
  • NHI 1991
  • Fundamental
  • Price
  • LGND $209.00
  • NHI $75.81
  • Analyst Decision
  • LGND Strong Buy
  • NHI Buy
  • Analyst Count
  • LGND 8
  • NHI 4
  • Target Price
  • LGND $144.71
  • NHI $82.75
  • AVG Volume (30 Days)
  • LGND 139.7K
  • NHI 202.0K
  • Earning Date
  • LGND 08-05-2025
  • NHI 11-06-2025
  • Dividend Yield
  • LGND N/A
  • NHI 4.83%
  • EPS Growth
  • LGND N/A
  • NHI 6.78
  • EPS
  • LGND N/A
  • NHI 3.14
  • Revenue
  • LGND $181,488,000.00
  • NHI $350,596,000.00
  • Revenue This Year
  • LGND $18.41
  • NHI $4.68
  • Revenue Next Year
  • LGND $18.87
  • NHI $10.60
  • P/E Ratio
  • LGND N/A
  • NHI $24.28
  • Revenue Growth
  • LGND 53.40
  • NHI 7.21
  • 52 Week Low
  • LGND $81.74
  • NHI $65.13
  • 52 Week High
  • LGND $129.90
  • NHI $82.32
  • Technical
  • Relative Strength Index (RSI)
  • LGND 78.49
  • NHI 51.57
  • Support Level
  • LGND $183.91
  • NHI $72.94
  • Resistance Level
  • LGND $193.02
  • NHI $76.29
  • Average True Range (ATR)
  • LGND 7.10
  • NHI 1.70
  • MACD
  • LGND 0.78
  • NHI 0.18
  • Stochastic Oscillator
  • LGND 96.77
  • NHI 81.00

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About NHI National Health Investors Inc.

National Health Investors Inc is a housing and medical facility REIT. The company operates through two reportable segments, i.e., Real Estate Investments and Senior Housing Operating Portfolio (SHOP). The Real Estate Investments segment, which generates maximum revenue, consists of real estate investments and leases, mortgages, and other notes receivables in independent living facilities, assisted living facilities, entrance fee communities, senior living campuses, skilled nursing facilities, and a hospital. The SHOP segment is comprised of two ventures that own the operations of independent living facilities. The company's revenues are derived in the form of rental income, mortgage and other notes receivable interest income, and resident fees and services.

Share on Social Networks: